Yes, there are several tests for RSV, ranging from rapid antigen tests that return results in under 30 minutes to more sensitive molecular tests that detect even small amounts of the virus. You can now even test for RSV at home with an over-the-counter kit. The type of test you get depends on your age, where you’re being tested, and what your doctor is looking for.
Types of RSV Tests
RSV testing falls into two main categories: antigen tests and molecular tests. Both use a nasal swab sample, but they work differently and vary significantly in accuracy.
Rapid antigen tests are the most common RSV test. They look for specific viral proteins in a fluid sample from your nose and can deliver results in under 30 minutes. The tradeoff is accuracy. Published sensitivity for antigen-based tests ranges from about 26% to 100%, meaning they can miss infections, particularly in adults and older children. Specificity ranges from roughly 80% to 100%.
Molecular tests (often called PCR or RT-PCR tests) look for the virus’s genetic material rather than proteins. Because they can detect much smaller amounts of virus, they’re significantly more accurate. Rapid molecular tests that return results in 30 minutes or less show sensitivity between 67% and 100% and specificity between 94% and 100%. In hospital settings specifically, sensitivity climbs to 98% or higher. These tests are the preferred option when accuracy matters most.
Why Accuracy Varies by Age
RSV tests tend to work better in young children than in adults, for a straightforward biological reason: infants and toddlers carry much higher levels of the virus in their noses. Adults with RSV generally have lower viral loads, which makes the virus harder to detect, especially with antigen tests. All the missed cases in one large community study of older adults had very low viral loads.
This is why molecular tests are often recommended for older children and adults. They’re sensitive enough to pick up the smaller amounts of virus that antigen tests can miss. For infants and young children, rapid antigen tests are more reliable because there’s simply more virus to find.
Multiplex Tests: RSV, Flu, and COVID in One Swab
Because RSV, influenza, and COVID-19 cause similar symptoms, many clinics now use multiplex tests that check for all three viruses from a single nasal sample. Both antigen and molecular versions of these panels exist. The CDC recommends molecular multiplex tests for symptomatic outpatients and hospitalized patients with acute respiratory illness, since they help doctors distinguish between infections that may need different treatments.
Some multiplex antigen tests are also available over the counter for home use, which brings us to a relatively new option.
At-Home RSV Testing
The FDA cleared the first at-home test that includes RSV in early 2025. The Flowflex Plus 4-in-1 test from Acon Laboratories detects RSV, influenza A, influenza B, and COVID-19 from a single nasal swab. It’s available without a prescription and cleared for use in adults and children as young as six months. For young children, an adult administers the test using a specially designed nasal swab guard.
This is an antigen-based test, so it has the same accuracy limitations as other rapid antigen tests. A negative result doesn’t completely rule out RSV, particularly in adults. But for families trying to figure out which virus is causing symptoms at home, it offers a practical first step.
What the Test Involves
RSV testing is noninvasive. A healthcare provider (or you, if using a home test) collects a sample by gently swabbing the inside of your nose. In clinical settings, this may be a nasopharyngeal swab that reaches further back, or a mid-turbinate swab that doesn’t go as deep. For young children, a nasal wash (saline flushed into the nose and collected) is sometimes used to get a better sample.
Rapid tests, whether antigen or molecular, typically return results within 15 to 30 minutes. Lab-based molecular tests may take several hours or longer, depending on the facility.
Cost and Insurance Coverage
In a clinical setting, the total charges for a combined COVID, flu, and RSV test panel range from roughly $605 to $832 before insurance, based on Cleveland Clinic’s published pricing. Most insurers currently cover this testing when a healthcare provider orders it as medically necessary for a symptomatic patient. Your actual out-of-pocket cost depends on your specific plan, so checking with your insurer beforehand is worthwhile if cost is a concern.
At-home multiplex tests are priced like other OTC rapid tests and are a significantly cheaper option for initial screening, though they sacrifice some accuracy compared to clinical molecular testing.
When Testing Matters Most
Not everyone with cold-like symptoms needs an RSV test. Testing is most useful for people at higher risk of severe illness: infants (especially those under six months), older adults, people with chronic heart or lung disease, and those with weakened immune systems. In these groups, confirming RSV can change treatment decisions and help with infection control.
For otherwise healthy older children and adults, RSV typically causes mild cold symptoms that resolve on their own. Testing in these cases is most helpful when symptoms are severe, when someone lives with or cares for a high-risk person, or when a doctor needs to rule out other treatable infections like the flu. If you do test at home and get a negative result but symptoms worsen, a clinical molecular test is the more reliable follow-up.